Osteoarthritis — an untreatable disease?
The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.
Abstract
Osteoarthritis is a painful and disabling disease that affects millions of patients. Its aetiology is largely unknown, but is most likely multi-factorial. Osteoarthritis poses a dilemma: it often begins attacking different joint tissues long before middle age, but cannot be diagnosed until it becomes symptomatic decades later, at which point structural alterations are already quite advanced. In this review, osteoarthritis is considered as a disease of the whole joint that may result from multiple pathophysiological mechanisms, one of which is the dysregulation of lipid homeostasis. No proven disease-modifying therapy exists for osteoarthritis and current treatment options for chronic osteoarthritic pain are insufficient, but new pharmacotherapeutic options are emerging.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a chronic disease characterized by degeneration of articular cartilage leading to pain and physical disability.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [10]
In the citing paper
“Aging and trauma are risk factors for the development of osteoarthritis (OA)10”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [10]
Citations
Cites
1 retracted
Yagami, K., Uyama, Y., Yoshizawa, Y., Kakuta, S., Yamaguchi, A., & NAGUMO, M. (2004) · Bone · doi:10.1016/j.bone.2003.12.016 · Cited by 17 · cited 1×
“Interestingly, adipocytes share a common mesenchymal stem-cell precursor with osteoblasts and chondrocyte”
BackgroundRetractedCan the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734 · cited 1×
“COX1 is constitutively expressed in many cell types, whereas COX2 is induced at the site of inflammation, although it is also constitutively expressed in the kidney, for exampl”
BackgroundLeptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048 · cited 1×
“It is recommended as a first-line oral analgesic for knee O”
BackgroundCharbonneau, D. H. (2005) · Europe PMC (PubMed Central) · Cited by 2,041
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735 · cited 1×
“Besides its role in regulating caloric intake, leptin regulates bone mass and mineralization through a neuroendocrine pathway involving the sympathetic nervous syste”
BackgroundWarner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A., & Vane, J. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7563 · Cited by 1,519
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Samad, T. A., Moore, K. A., Sapirstein, A., Billet, S., Allchorne, A., Poole, S., Bonventre, J. V., & Woolf, C. J. (2001) · Nature · doi:10.1038/35068566 · Cited by 1,281
Research works printed but not linked: 6
- Harris, E. D. Jr. The Bone and Joint decade: a catalyst for progress. Arthritis Rheum 44, 1969–1970 (2004). · doi:10.1002/1529-0131(200109)44:9<1969::aid-art342>3.0.co;2-a
- Brandt, K. D., Smith, G. N. Jr & Simon, L. S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum. 43, 1192–1203 (2000). · doi:10.1002/1529-0131(200006)43:6<1192::aid-anr2>3.0.co;2-l
- Bingham, C. et al. Clinically significant placebo improvement occurs by 6 months and is maintained through 24 months in a study of knee OA pain and function. Osteoarthr. Cartil. 12, S132 Abs. P323 (2004).
- Flechtenmacher, J. et al. Bradykinin-receptor-inhibition — a therapeutic option in osteoarthritis? Osteoarthr. Cartil. 12, S137 Abs. P332 (2004).
- Ding, C & Cicuttini, F. Licofelone (Merckle). IDrugs 6, 802–808 (2003).
- Schnitzer, T. J., Kivitz, A. J., Lipetz, S., Sanders, N. & Hee, A. A Phase II study of the efficacy and safety of AZD3582, a CINOD, in subjects with osteoarthritis of the knee. Eur. League Against Rheumatism 2004 Conference Abs OP0016 [online], < http://mcic3.textor.com/cgi-bin/mc/printabs.pl?APP=eular2004SCIE-abstract&TEMPLATE=&keyf=0094&showHide=show&client= > (2004)
Cited by
Items 201–300 of 592
Lü, X., Lin, J., Jin, J., Qian, W., & Weng, X. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2446 · Cited by 31
Notch ligand Jagged1 promotes mesenchymal stromal cell-based cartilage repair
Sun, J., Luo, Z., Wang, G., Wang, Y., Wang, Y., Olmedo, M. L., Morandi, M., Barton, R. S., Kevil, C. G., Shu, B., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0151-9 · Cited by 32
Low-dose radiation therapy for osteoarthritis and enthesopathies: a review of current data
Javadinia, S. A., Nazeminezhad, N., Ghahramani‐Asl, R., Soroosh, D., Fazilat‐Panah, D., PeyroShabany, B., Saberhosseini, S. N., Mehrabian, A., Taghizadeh‐Hesary, F., Nematshahi, M., et al. (2021) · International Journal of Radiation Biology · doi:10.1080/09553002.2021.1956000 · Cited by 31
Insights into the implementation of Fibronectin 1 in the cartilage tissue engineering
Alahdal, M., You, W., Huang, R., Huang, J., Deng, Z., Duan, L., Wang, D., Li, W., & Sun, W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112782 · Cited by 33
Man, G., Yang, H., Shen, K., Zhang, D., Zhang, J., Wu, H., Zhang, H., & Wang, J. (2022) · Journal of Immunology Research · doi:10.1155/2022/4370873 · Cited by 30
“Besides, the homeostasis of ECM components, mainly the aggrecan and collagen II, could be disturbed by the abnormal levels of in fl ammatory cytokines released by chondrocytes [4].”
RetractedMi, W., Mao‐Ying, Q., Liu, Q., Wang, X., Wang, Y., & Wu, G.-C. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.04.008 · Cited by 31
Perreault, K., Courchesne‐Loyer, A., Fortier, M., Maltais, M. L., Barsalani, R., Riesco, É., & Dionne, I. J. (2015) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0411-7 · Cited by 30
Strategies for Improving the Repair of Focal Cartilage Defects
Abdel-Sayed, P., & Pioletti, D. P. (2015) · Nanomedicine · doi:10.2217/nnm.15.119 · Cited by 31
Borel, M., Pastoureau, P., Papon, J., Madelmont, J. C., Moins, N., Maublant, J., & Miot‐Noirault, E. (2009) · Journal of Proteome Research · doi:10.1021/pr8009963 · Cited by 29
Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC-derived chondrocytes
Rainbow, R., Kwon, H., Foote, A., Preda, R. C., Kaplan, D., & Zeng, L. (2013) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.04.011 · Cited by 29
Kim, G.-W., Han, M.-S., Park, H.-R., Lee, E.-J., Jung, Y., Usmani, S. E., Ulici, V., Han, S. W., & Beier, F. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.01.016 · Cited by 29
Animal Models of Osteoarthritis: Updated Models and Outcome Measures 2016–2023
Chapman, J. H., Ghosh, D., Attari, S., Ude, C. C., & Laurencin, C. T. (2023) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-023-00309-x · Cited by 34
“Figure 1 demonstrates classic radiographic features of joint space narrowing, osteophytes (bone spurs), subchondral sclerosis, and subchondral cysts [20].”
Novak, S. D., Guerron, G., Zou, Z., Cheung, G., & Berteau, J. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001409 · Cited by 28
Moo, E. K., Ebrahimi, M., Sibole, S. C., Tanska, P., & Korhonen, R. K. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.09.002 · Cited by 34
Early knee osteoarthritis management should first address mechanical joint overload
Arendt, E. A., Miller, L. E., & Block, J. E. (2014) · Orthopedic Reviews · doi:10.4081/or.2014.5188 · Cited by 28
Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
Vedadghavami, A., Mehta, S., & Bajpayee, A. G. (2020) · Journal of Visualized Experiments · doi:10.3791/61340 · Cited by 27
Aigner, T. G., Schmitz, N., & Haag, J. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.29 · Cited by 27
Scott, I. C., Midha, A., Rashid, U., Ball, S. T., Walding, A., Kerry, P. J., Delaney, S. J., & Cruwys, S. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.09.016 · Cited by 26
Selective Th2 Upregulation by Crocus sativus: A Neutraceutical Spice
Bani, S., Pandey, A., Agnihotri, V. K., Pathania, V., & Singh, B. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2011/639862 · Cited by 26
Crosstalk between gut microbiota and osteoarthritis: A critical view
Korotkyi, O., Kyriachenko, Y., Kobyliak, N. M., Falalyeyeva, T. M., & Остапченко, Л. І. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103904 · Cited by 31
Is it time to redefine the role of low-dose radiotherapy for benign disease?
Montero, A., Sabater, S., Rödel, F., Gaipl, U. S., Ott, O. J., Seegenschmiedt, M. H., & Arenas, M. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214873 · Cited by 26
Osteoarthritis: More than Cartilage Degeneration
Castañeda, S., & Vicente, E. F. (2017) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-017-9228-6 · Cited by 30
Xu, Z., Shen, Z., Wu, B. Y., Gong, S., & Chen, B. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30392 · Cited by 25
“DMM, destabilization of the medial meniscus; OA, osteoarthritis mainly consists of type II collagen and aggrecan, is considered as its hallmark (Wieland et al., 2005).”
BackgroundHuh, J., Seo, B.-K., Baek, Y.-H., Lee, S., Lee, J.-D., Choi, D., & Park, D. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-256 · Cited by 25
Association of vitamin D and knee osteoarthritis in younger individuals
Tripathy, S. K., Gantaguru, A., Nanda, S. N., Velagada, S., Srinivasan, A., & Mangaraj, M. (2020) · World Journal of Orthopedics · doi:10.5312/wjo.v11.i10.418 · Cited by 25
Lach, M., Trzeciak, T., Richter, M., Pawlicz, J., & Suchorska, W. M. (2014) · Journal of Tissue Engineering · doi:10.1177/2041731414552701 · Cited by 30
Khoshgoftar, M., Wilson, W., Ito, K., & van Donkelaar, C. C. (2012) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-012-0452-1 · Cited by 24
Wang, W., Zhong, B., Sun, J., Cao, J., Tian, J., Zhong, N., Zhao, W., Tian, L., Xu, P., Guo, D., et al. (2011) · Rheumatology · doi:10.1093/rheumatology/ker230 · Cited by 25
You, H., Zhang, R., Wang, L., Pan, Q., Mao, Z., & Huang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.634822 · Cited by 27
“Osteoarthritis (OA) is a degenerative disease which is common in elderly individuals and is characterized by an inflammatory response and cartilage degeneration (Wieland et al., 2005; Martel-Pelletier et al., 2016).”
BackgroundSenotherapeutics in Cancer and HIV
Sánchez-Díaz, L., Espinosa-Sánchez, A., Blanco, J. R., & Carnero, A. (2022) · Cells · doi:10.3390/cells11071222 · Cited by 29
Sancheti, P. K., Shetty, V. D., Dhillon, M. S., Sprague, S., & Bhandari, M. (2017) · Clinics in Orthopedic Surgery · doi:10.4055/cios.2017.9.3.286 · Cited by 24
Chen, H., Cai, T., Ruan, X., Jiao, C., Xia, J., Wei, X., Wang, Y., Gong, P., Li, H., Atkin, R., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c12552 · Cited by 23
Lessons from the proteomic study of osteoarthritis
Ruíz‐Romero, C., Fernández‐Puente, P., Calamia, V., & Blanco, F. J. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1065182 · Cited by 23
Ishihara, T., Kakiya, K., Takahashi, K., Miwa, H., Rokushima, M., Yoshinaga, T., Tanaka, Y., Ito, T., Togame, H., Takemoto, H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.027 · Cited by 25
Hakshur, K., Benhar, I., Bar-Ziv, Y., Halperin, N., Segal, D., & Eliaz, N. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.08.030 · Cited by 23
Local delivery of a carbohydrate analog for reducing arthritic inflammation and rebuilding cartilage
Kim, C., Jeon, O. H., Kim, D. H., Chae, J. J., Shores, L. S., Bernstein, N., Bhattacharya, R., Coburn, J. M., Yarema, K. J., & Elisseeff, J. H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.029 · Cited by 25
Kubomura, D., Ueno, T., YAMADA, M., Tomonaga, A., & Nagaoka, I. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4140 · Cited by 23
Cormier, J., Cone, K., Lanpher, J., Kinens, A., Henderson, T., Liaw, L., Bilsky, E. J., King, T. E., Rosen, C. J., & Stevenson, G. W. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.05.011 · Cited by 24
Kaczocha, M., Azim, S., Nicholson, J., Rebecchi, M. J., Lu, Y., Feng, T., Romeiser, J. L., Reinsel, R. A., Rizwan, S., Shodhan, S., et al. (2018) · BMC Anesthesiology · doi:10.1186/s12871-018-0489-5 · Cited by 29
In vivo visualization of osteoarthritic hypertrophic lesions
Hu, H., Lim, N. H., Juretschke, H.-P., Ding‐Pfennigdorff, D., Florian, P., Kohlmann, M., Kandira, A., von Kries, J. P., Saas, J., Rudolphi, K. A., et al. (2015) · Chemical Science · doi:10.1039/c5sc01301a · Cited by 22
Self-citationSalvianolic Acid A Has Anti-Osteoarthritis Effect In Vitro and In Vivo
Wu, Y., Wang, Z., Zeng, L., Fu, X., Zhan, J., & Yu, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00682 · Cited by 23
“These are very important to the biomechanical properties of cartilage and provide key elastic supports for joint activities (Wieland et al., 2005; Sarin et al., 2019).”
BackgroundFeng, J., Kim, H.-Y., Sim, S.-M., Zuo, G., Jung, J.-S., Hwang, S.-H., Kwak, Y.-G., Kim, M., Jo, J.-H., Kim, S.-C., et al. (2021) · Plants · doi:10.3390/plants10061234 · Cited by 23
de Vinuesa, A. G., Sánchez‐Duffhues, G., Blaney‐Davidson, E., van Caam, A., Lodder, K., Ramos, Y. F., Kloppenburg, M., Meulenbelt, I., van der Kraan, P. M., Goumans, M., et al. (2021) · The Journal of Pathology · doi:10.1002/path.5774 · Cited by 22
Jia, X., Ma, J., Chen, X., Li, W., Zhou, X., Lei, B., Zhao, X. G., & Mao, Y. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100277 · Cited by 26
Exploration of novel drug delivery systems in topical management of osteoarthritis
Patil, P., Nene, S., Shah, S., Singh, S. B., & Srivastava, S. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01229-z · Cited by 24
“Intra-articular injections containing corticosteroids and hyaluronic acid (Hyalgan®) have also demonstrated efficacy in providing symptomatic relief [11].”
BackgroundKaroichan, A., Boucenna, S., & Tabrizian, M. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12435 · Cited by 26
“However, as it is now recognized as a disease of the whole joint, EV-based therapies need to address all tissues within the osteochondral unit to allow proper healing and attenuation of the disease (Wieland et al., 2005).”
BackgroundThe Properties of Chondrocyte Membrane Reservoirs and Their Role in Impact-Induced Cell Death
Moo, E. K., Amrein, M. A., Epstein, M., Duvall, M., Osman, N. A. A., Pingguan‐Murphy, B., & Herzog, W. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.08.035 · Cited by 24
Molecular monitoring of equine joint homeostasis
de Grauw, J. C. (2011) · Veterinary Quarterly · doi:10.1080/01652176.2011.565546 · Cited by 25
Goudarzi, R., Taylor, J. F., Yazdi, P. G., & Pedersen, B. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12176 · Cited by 23
Zhang, J., Zhang, S., Zhou, Y., Qu, Y., Hou, T., Ge, W., & Zhang, S. (2022) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-022-03247-6 · Cited by 24
“Its etiology has not yet been identified, but many risk factors, including heredity, sex, joint injury, age, and obesity, should be taken into account [2].”
BackgroundFrom gristle to chondrocyte transplantation: treatment of cartilage injuries
Lindahl, A. H. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0369 · Cited by 21
Kubomura, D., Ueno, T., YAMADA, M., & Nagaoka, I. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4849 · Cited by 21
Sladek, S., Kearney, C., Crean, D., Brama, P. A. J., Tajber, L., Fawcett, K., Labberté, M. C., Leggett, B., & Brayden, D. J. (2018) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-0557-x · Cited by 25
“Increased levels of inflammatory cytokines released from chondrocytes initiate a further increase in the production of IL-1β and collagen-destroying matrix metalloproteinases (MMPs) [2, 3].”
BackgroundTsubosaka, M., Matsumoto, T., Sobajima, S., Matsushita, T., Iwaguro, H., & Kuroda, R. (2021) · Cell Transplantation · doi:10.1177/09636897211067454 · Cited by 21
“All authors have made substantial contributions to (1) the conception and design of the study, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be submitted.”
BackgroundPerturbation of nuclear lamin A causes cell death in chondrocytes
Attur, M. G., Ben‐Artzi, A., Yang, Q., Al-Mussawir, H., Worman, H. J., Palmer, G. D., & Abramson, S. B. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34360 · Cited by 23
“Over the past decade, there have been significant developments in the scientific understanding of OA, including the identification of a variety of mediators and signaling pathways that contribute to cartilage and bone remodeling (1;2).”
BackgroundIntra-operative Raman spectroscopy and ex vivo Raman mapping for assessment of cartilage degradation
Gaifulina, R., Nunn, A., Draper, E. R. C., Strachan, R. K., Blake, N., Firth, S., Thomas, G. M. H., McMillan, P. F., & Dudhia, J. (2021) · Clinical Spectroscopy · doi:10.1016/j.clispe.2021.100012 · Cited by 20
Zhang, S., Zhang, B., Liao, Z., Chen, Y., Guo, W., Wu, J., Liu, H., Weng, R., Su, D., Chen, G., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.02.027 · Cited by 22
Park, D. R., Ko, R., Kwon, S. H., Min, B., Yun, S. H., Kim, M. H., Minatelli, J., Hill, S., & Lee, S. Y. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3787 · Cited by 21
Mendel, K., Eliaz, N., Benhar, I., Hendel, D., & Halperin, N. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.06.003 · Cited by 20
Clark, A. L. (2007) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e31815e4217 · Cited by 20
How Close are We to Having Structure-Modifying Drugs Available?
Hunter, D. J., & Graverand‐Gastineau, M. H. L. (2008) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2008.05.003 · Cited by 24
Eliaz, N., & Hakshur, K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3942-4_10 · Cited by 20
“serum and urine) [42, 55, 90, 91, 94].”
BackgroundViscosupplementation in Patients with Osteoarthritis of the Knee
Cianflocco, A. J. (2013) · Postgraduate Medicine · doi:10.3810/pgm.2013.01.2618 · Cited by 19
Lv, Q., Zhao, X., Teng, S., Jin, X., Zhou, Y. C., Sun, Y., Pei, H., Yan, Z., & Ma, C. (2025) · Advanced Science · doi:10.1002/advs.202503939 · Cited by 26
Black, R. M., Wang, Y., Struglics, A., Lorenzo, P., Chubinskaya, S., Grodzinsky, A. J., & Önnerfjord, P. (2021) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2021.100191 · Cited by 19
Tnibar, A. (2022) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2022.104143 · Cited by 19
Controlling Microenvironments with Organs-on-Chips for Osteoarthritis Modelling
Ong, L. J. Y., Fan, X., Sun, A. R., Mei, L., Toh, Y., & Prasadam, I. (2023) · Cells · doi:10.3390/cells12040579 · Cited by 22
“The OA pathophysiology complexities further contribute to the lack of validated models that systematically study the mechanism and provide a suitable screening platform for drug discovery [5].”
BackgroundWu, Q., & Henry, J. L. (2009) · Molecular Pain · doi:10.1186/1744-8069-5-57 · Cited by 19
Lockwood, S., & Dickenson, A. (2019) · European Journal of Pain · doi:10.1002/ejp.1386 · Cited by 18
Delivering Agents Locally into Articular Cartilage by Intense MHz Ultrasound
Nieminen, H. J., Ylitalo, T., Suuronen, J., Rahunen, K., Salmi, A., Saarakkala, S. S., Serimaa, R. E., & Hæggström, E. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.03.025 · Cited by 19
“Therefore, local administration of the drug could potentially enhance the therapeutic effect within the degenerated tissue while avoiding adverse effects elsewhere in the body (Wieland et al. 2005).”
BackgroundDrug delivery strategies for cathepsin inhibitors in joint diseases
Wang, D., & Brömme, D. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.6.1015 · Cited by 21
Low-dose radiation therapy for hand osteoarthritis: shaking hands again?
Álvarez, B., Montero, A., Alonso, R., Valero, J., López, M., Ciérvide, R., Sánchez, E., Hernando, O., Garcia-Aranda, M., Martı́, J., et al. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02710-w · Cited by 18
Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis
Kondreddy, V. K. R., Banerjee, R., Devi, B. L. A. P., Muralidharan, K., & Selvakumar, P. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01547-4 · Cited by 18
“The arachidonic acid (AA) dependent metabolites namely prostaglandin E 2 (PGE 2 ) and leukotriene B 4 (LTB 4 ) play a crucial role in the regulation of pain, inflammation, and cartilage degeneration [3, 8].”
BackgroundPathophysiology of osteoarthritis.
Carmona, J. U., & Prades, M. (2009) · Cited by 18
Are there promising biologic therapies for osteoarthritis?
Hunter, D. J. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0004-y · Cited by 18
Park, S., Oh, J., Kim, Y., Choe, S., Chun, C. H., & Jin, E. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3356 · Cited by 18
Lou, X., Zhou, Q., Dong, Z., Bai, L., Su, J., & Yue, H. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.07.010 · Cited by 17
“In OA models, bioprinting enables spatially controlled deposition of chondrocytes, synovial cells, and inflammatory factors, thereby reconstructing the pathological OA microenvironment [76].”
Olariu, L. (2018) · FARMACIA · doi:10.31925/farmacia.2018.3.19 · Cited by 17
“Having multiple aetiologies, osteoarthritis is a difficult to treat pathology, usually pharmacological interventions solely addressed to chronic pain fail and do not prevent cartilage damage and the associated destruction of other joint tissues [20].”
BackgroundComparison of glucose derivatives effects on cartilage degradation
Phitak, T., Pothacharoen, P., & Kongtawelert, P. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-162 · Cited by 17
Faust, H. J., Guo, Q., & Elisseeff, J. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00053-9 · Cited by 23
Nitric oxide-modulating biomaterials for therapeutic Immunoengineering
Boo, Y., Choi, S., Kim, J., & Kim, W. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115718 · Cited by 18
Álvarez, B., Montero, A., Hernando, O., Ciérvide, R., García, J. D., López, M., Garcia-Aranda, M., Chen, X., Flores, I., Sánchez, E., et al. (2021) · British Journal of Radiology · doi:10.1259/bjr.20200809 · Cited by 16
Chen, Z., Xue, X., Li, Q., Song, Y., Xu, H., Wang, W., & Hua, Y. (2023) · International Orthopaedics · doi:10.1007/s00264-023-05721-0 · Cited by 16
Assembled nanomedicines as efficient and safe therapeutics for articular inflammation
Che, L., Zhou, J., Li, S., He, H., Zhu, Y., Zhou, X. W., Jia, Y., Liu, Y., Zhang, J., & Li, X. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.017 · Cited by 16
Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping
Sogame, S., Suenaga, Y., Atobe, M., Kawanishi, M., Tanaka, E., & Miyoshi, S. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.075 · Cited by 16
Shao, J., Lin, L., Tang, B. H., & Du, C. (2014) · RSC Advances · doi:10.1039/c4ra08997a · Cited by 16
Służalska, K. D., Liebisch, G., Wilhelm, J., Ishaque, B. A., Hackstein, H., Schmitz, G., Rickert, M., & Steinmeyer, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-14004-9 · Cited by 16
Chen, Z., He, L., Di, J., Huang, L., Feng, F., Yang, B., Xie, P., & Rong, L. (2022) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-022-04595-y · Cited by 16
“The aforementioned risk factors in LFJOA are also well-known and well-documented in many studies of OA in other weight-bearing joints, such as knee OA [27, 28].”
BackgroundPohlig, F., Guell, F., Lenze, U., Lenze, F. W., Mühlhofer, H., Schauwecker, J., Toepfer, A., Mayer‐Kuckuk, P., von Eisenhart‐Rothe, R., Burgkart, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150020 · Cited by 16
Gao, S., Qi, X., Li, J., & Sang, L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.143 · Cited by 16
Arias, C., Saavedra, N., Saavedra, K., Marysol Alvear, Z., Cuevas, A., Maria–Engler, S. S., Abdalla, D. S. P., & Salazar, L. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153768 · Cited by 16
“Currently, there are no drugs available to modify OA and a large number of candidate drugs have failed to demonstrate efficacy or they were associated with significant side effects [23,42].”
BackgroundLöfgren, M., Svala, E., Lindahl, A. H., Skiöldebrand, E., & Ekman, S. (2018) · Research in Veterinary Science · doi:10.1016/j.rvsc.2018.04.013 · Cited by 19
Chaturvedi, P., Pratta, M. A., Steplewski, K. M., Connor, J., & Kumar, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22170 · Cited by 16
Circ0083429 Regulates Osteoarthritis Progression via the Mir-346/SMAD3 Axis
Teng, Y., Yang, Y., Xie, Z., Xu, Y., Huang, Y., Gao, J., Shen, S., Ye, H., Iranmanesh, Y., Fan, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.579945 · Cited by 16
Zhang, R., Meng, F., Zhang, Q., Zou, Z., Xiao, K., Zhu, T., Li, H., Zhang, W., Ma, J., & Ma, J. (2021) · PubMed Central · Cited by 15
Radiotherapy for ostheoarticular degenerative disorders: When nothing else works
Álvarez, B., Montero, A., Aramburu, F., Calvo-Aranda, E., de la Casa, M. Á., Valero, J., Hernando, O., López, M., Ciérvide, R., Garcia-Aranda, M., et al. (2019) · Osteoarthritis and Cartilage Open · doi:10.1016/j.ocarto.2019.100016 · Cited by 15
Yang, S., Jawahar, R., McAlindon, T. E., Eaton, C. B., & Lapane, K. L. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-86 · Cited by 15
Translational animal models using veterinary patients – An example of canine osteoarthritis (OA)
Vainio, O. (2012) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2011.11.007 · Cited by 15
“The etiology ofOA is largely unknown, but ismost likelymultifactorial [22].”
BackgroundInfluentialHydrophilic/Hydrophobic Janus Nanofibers Containing Compound K for Cartilage Regeneration
Shin, H., Park, J., Kim, Y.-J., Kim, D., Jin, E., & Ryu, J. H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s435156 · Cited by 16
Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study
Başer, O., Isenman, L., Baser, S., & Samayoa, G. (2024) · Obesity Science & Practice · doi:10.1002/osp4.762 · Cited by 15
Metadata
- Authors
- Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A.
- Affiliations
- Sanofi (Germany) (DE)
- Corresponding author
- Wieland, Heike A.
- ORCID
- Michaelis, Martin
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-04
- Volume
- 4
- Issue
- 4
- Pages
- 331-344
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1487036716
- Cited by
- 585
- References
- 124
- Citations by year
- 2026: 34 · 2025: 32 · 2024: 44 · 2023: 31 · 2022: 36 · 2021: 34 · 2020: 25 · 2019: 36 · 2018: 24 · 2017: 31 · 2016: 26 · 2015: 29 · 2014: 29 · 2013: 32 · 2012: 29
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacological Effects of Medicinal Plants
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- osteoarthritis, disease-modifying therapy, early-onset osteoarthritis, pharmacotherapy, treatment options
- MeSH terms
- Anti-Inflammatory Agents, Non-Steroidal, Humans, Osteoarthritis, Pain, Drug Design, Molecular Structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.